Hydrogen-Releasing Nanoparticles in Lab Cell Studies of Cancer
Acid-responsive H <sub>2</sub> -releasing Fe nanoparticles for safe and effective cancer therapy
Research hubs: Immune System
This research was done on cells or tissue in a lab, not in people or animals.

- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Zhu Kou, Penghe Zhao, Zhihao Wang, Zhaokui Jin, Lihua Chen, Bao-Lian Su, Qianjun He
- Journal
- Journal of Materials Chemistry B
- Year
- 2019
- PMID
- 32255077
- Study Type
- Cell Culture
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 85 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Scientists have developed tiny, smart particles that can deliver hydrogen gas directly to tumors, enhancing the effectiveness and safety of hydrogen-based cancer treatment.
Key Finding
Iron nanoparticles engineered to release hydrogen gas specifically in acidic tumor environments demonstrated effective tumor growth inhibition in laboratory and animal models with high biocompatibility.
Summary
Researchers developed tiny iron particles coated with a natural polymer that can deliver hydrogen gas directly to tumors. The particles are designed to accumulate in cancer cells and release hydrogen in response to the acidic environment inside tumors. In laboratory and animal studies, these particles showed promise in slowing tumor growth while appearing safe to normal tissues.
Practical Takeaway
This is early-stage research in animals and cell cultures, not yet tested in humans. While the results are promising for a new hydrogen delivery approach to cancer, it remains a laboratory discovery and cannot yet inform decisions about hydrogen water or any consumer products. Human clinical trials would be needed to determine if this strategy is safe and effective for cancer patients.
Abstract (excerpt)
Hydrogen therapy is an emerging and promising strategy for the treatment of inflammation-related diseases owing to the excellent bio-safety of hydrogen molecules (H 2 ), but is facing a challenge that the H 2 concentration at the local disease site is hardly accumulated because of its high…